Drew Amorosi

1 month ago | healio.com | Drew Amorosi |Mindy Valcarcel

HHS Secretary Robert F. Kennedy, Jr., has signed an extension of a public health emergency declaration to address the opioid crisis in the United States, according to an agency press release. The extension lasts 90 days and provides the HHS secretary with specific expanded authorities to deal with the declared emergency that are outlined in section 319 of the Public Health Service Act.

1 month ago | healio.com | Drew Amorosi |Kathleen N. Mueller

I started thinking about a career in medicine in high school. My mom loved and respected our family doctor — I am one of 4 children, so she was very familiar with the office! — and I set up a meeting with Tim Ryan, MD. It was my first glimpse into the world of family medicine, and there was no going back. Senior year in college, I decided to delay my application to medical school (much to my parents’ dismay) to spend a year in the Jesuit Volunteer Corps in Mobile, Alabama.

2 months ago | healio.com | Emma Bascom |Drew Amorosi

Key takeaways: Martin Makary, MD, MPH, has been nominated to lead the FDA. Discussion about the recently canceled meeting to select the components for next year’s flu vaccine was a major theme in the hearing. Lawmakers grilledMartin Makary, MD, MPH, on transparency, his plans for mifepristone and his stance on the recently cancelled Vaccine Advisory Committee meeting during Thursday’s senate hearing to be the next FDA commissioner.

2 months ago | healio.com | Andrew Rhoades |Drew Amorosi

Key takeaways: Those with the highest consumption of plant-based oils had a 16% lower death risk. Plant-based oils also lowered the risk for mortality from cancer and CVD by 11%. Adults who consume a large amount of butter have a 15% greater mortality risk, according to an analysis published in JAMA Internal Medicine. But, opting to replace this consumption with plant-based oils instead could significantly lower the risk for death from all causes and cancer.

2 months ago | healio.com | Andrew Rhoades |Drew Amorosi

Key takeaways: GLP-1s reduced depression risk vs. DPP-4 inhibitors but not SGLT2 inhibitors. However, both GLP-1s and SGLT2 inhibitors may offer similar antidepressant benefits, researchers noted. The use of GLP-1 receptor agonists corresponded with a lower risk for depression among older adults with type 2 diabetes compared with dipeptidyl peptidase 4 inhibitors, results of a target trial emulation study suggested.